University of Akron professor Hossein Tavana and his colleagues are developing tools that could dramatically speed up creation of the next generation of drugs to treat an aggressive form of breast cancer.
If all goes well, these tools could be available to pharmaceutical companies in five or six years, likely through OncoSolutions LLC, the spinoff company the researchers and the University of Akron Research Foundation have created to commercialize the tools.
Click here to read the complete article.
Story excerpt provided by Crain’s Cleveland Business.
Written by Marc Vanac.
Originally published August 17, 2019.